| S.No |
Funding agency |
Sanction Year |
Title of the project |
Principal Investigator /Co-Principal Investigator |
Reference Number |
| 1 |
Indian Council of Medical Research (ICMR) |
2024-25 |
Development of Microneedle Array Patch Based Haemophilus Influenza Type-B (Hib) Vaccine Delivery System for Improved Logistics and Better Patient Compliance. |
Prof. Buchi N Nalluri/ Dr. Chandra Teja Uppuluri |
IIRPSG-2024-01-04481 |
| 2 |
KLEF |
2023-24 |
Vaccine delivery using Microneedle Array Patches to Overcome Last
Mile Logistics Issues, Thermal Instability, and Improve Patient
Compliance |
Dr. Chandra Teja Uppuluri/ Prof. Buchi N Nalluri |
KLEF/SRG/2023-24/Pharmacy/002 |
| 3 |
SERB-EMEQ |
2023 |
Pharmacological modulation of platelet glucose metabolism,
mitochondrial dysfunction, and platelet aggregation against co-morbid
conditions of Diabetes mellitus and Ischemic stroke |
Dr K Ramakrishna |
EEQ/2023/000766 |
| 4 |
DBT |
2023 |
Development of Microneedle Sensor Based Device for Continuous
Monitoring of Lactate in Point of Care Testing using Dermal Interstitial
Fluid |
Prof. Buchi N Nalluri/Dr. Pradeep Kumar |
BT/PR49884/MED/32/888/2023 |
| 5 |
KLEF
|
2022-23 |
Development And Validation Of Rp-Hplc-Pda Method For Quantification Of Metoprolol Succinate In Bulk And Dosage Form |
Dr. Buchi N Nalluri |
KLEF/SRG/2022-23/Pharmacy/001 |
| 6 |
KLEF
|
2022-23 |
Comparative Acute Toxicity Of Carbamate Pesticides Propoxur And Aldicarb In Vivo Exposed Zebra Fish |
Dr. Naresh Dumala |
KLEF/SRG/2022-23/Pharmacy/002 |
| 7 |
KLEF
|
2022-23 |
Evaluation Of Heterocyclic Analogues Against Mmpl3 Protein As Potent Antitubercular Agents: Design And Synthesis |
Dr. J Risy Namratha |
KLEF/SRG/2022-23/Pharmacy/003 |
| 8 |
KLEF
|
2021-22 |
Study Of In Vitro Anti-Oxidant And Anti-Diabetic Activity Leaf Extracts Of Lindernia Parviflora Haines |
Dr. M Narender |
KLEF/SRG/2021-22/Pharmacy/001 |
| 9 |
KLEF
|
2021-22 |
Phytochemical Extraction, GC-MS Characterization Of Hedyotis Aspera And In Silico Evaluation Of Reported Compounds For Diabetes Mellitus |
Dr. Alavala Rajasekar Reddy |
KLEF/SRG/2021-22/Pharmacy/002 |
